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a b s t r a c t
The decision to retrieve chronically implanted abandoned leads and trapped intracardiac
devices percutaneously has been difﬁcult and highly controversial. We present two case
reports in which electrophysiological ablation catheter was used to retrieve infected aban-
doned pacemaker lead and trapped permacatheter (permacath) in right ventricle. We could
avert major cardiovascular surgeries in both the patients by simply modifying the tradition-
ally used techniques for extraction of intracardiac devices.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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There was emergence of vascular and intracardiac interven-
tions in the past decade.1–3 As implant rate of Cardiovascular
Implantable Electronic Devices (CIED) continues to rise in most
countries, observed complications have increased in parallel.4
The occurrence of more frequent device system revisions for
complications,4 system upgrades,5 and/or lead malfunction6
and longer patient life expectancies have mandated a paradigm
shift toward premeditated lead management strategies from* Corresponding author.
E-mail address: dilipcardio@gmail.com (D. Kumar).
http://dx.doi.org/10.1016/j.ihj.2015.09.008
0019-4832/# 2015 Cardiological Society of India. Published by Elsevieimplant to removal or replacement. There has also been
increase in incidence of left-out broken catheters or leads of
previous CIED. Consequently, clinicians increasingly are
faced with the challenging choice of extraction or abandon-
ment of sterile, superﬂuous leads. Traditionally, forceps,
snares, baskets, locking stylets or lead-transection devices
and laser sheaths are used to extract leads and fragments. We
present ﬁrst two case reports of use of EP Catheter in retrieval
of trapped intracardiac devices (abandoned permanent
pacemaker lead and fragment of permacatheter) along with
traditional methods.r B.V. All rights reserved.
Fig. 2 – EP catheter hooking the old ventricular lead.
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A 55-year-old, normal-built male patient, with permanent
pacemaker, presented to the outpatient department with
complaints of intermittent fever for the past six months. He
had past medical history of type 2 diabetes mellitus and the
pacemaker was implanted 8 years back. Pulse generator was
removed and permanent pacemaker reimplantation was done
with new leads 8 months back. Patient developed infected
wound at PPI site with sinus cavity, which was operated after
one month of pacemaker reimplantation. Patient was asymp-
tomatic for one month, but later, he developed high-grade
fever, and was treated by various physicians. Recent transe-
sophageal echocardiography revealed multiple small vegeta-
tions attached to PPI leads, and two months back, blood culture
grew Staphylococcus aureus, and the patient was advised open
cardiotomy for chronically implanted leads removal. Patient
was asymptomatic and his blood culture was sterile when he
presented to us. Patient was admitted in cardiothoracic
surgery department for cardiotomy. After discussion with
cardiothoracic surgery department, endovascular approach
was successfully tried and permanent device was safely
reimplanted in the same sitting. As seen in Fig. 1, there was
one pacemaker lead and another abandoned lead (two
ventricular leads); we took out the lead connected with pulse
generator (functional lead) using standard procedure of
retrieval. After local dissection over the pacemaker, the lead
was unscrewed and stylet was passed and lead could be
brought out easily with gentle traction. The other old lead with
implant duration of 84 months had one end into right ventricle
(RV) and other end lying around superior vena cava (SVC) and
subclavian junction. The 7-French (7F) EP ablation catheter
was used as shown in Fig. 2 to hook the lead and pull into the
Inferior vena cava (IVC), which was in turn caught with snare
and taken out through right femoral vein. There was only TPIFig. 1 – Two old ventricular leads with temporary
pacemaker lead in place.lead seen in Fig. 3. The extraction time for this lead was 10 min
and ﬂourotime was 25 min. There was no periprocedural
complication.
3. Case report 2
A 25-year-old female patient who was on regular hemodialy-
sis, with permacath implanted three months back, presented
with complaints of fever that was lasting for the past two
weeks. Patient was a known case of systemic lupus erythe-
matosus and membranoproliferative glomerulonephritis, andFig. 3 – Old pacemaker leads removed and temporary
pacemaker lead in place.
Fig. 5 – EP catheter hooking the permacatheter.
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of tuberculosis and aortic valve replacement surgery was done
5 years back. The decision to take out permacath was taken, as
no other evident reason for fever was found. While taking out
the permacath, a fragment of it was mistakenly left inside the
venous system. After a failed attempt of local retrieval of the
left out permacath by the surgeon, endovascular retrieval was
tried. As seen in Fig. 4, one end of the permacath was in RV and
other end was in Jugular vein. To facilitate snaring from
femoral vein, we needed at least one free end hanging into IVC
or Right Atrium. We tried diagnostic EP catheter but it failed to
give much traction. Then we used 7F ablation catheter to hook
the permacath (Fig. 5) and was pulled out into IVC following
which the IVC end was caught with snare and brought out. EP
catheter was used to hook the trapped permacath to bring it
into the IVC because of its ability to change the curve distally.
Total duration of the extraction was 18 min and ﬂourotime
was only 4 min. Fig. 6 shows the extracted fragment of the
permacath. There was no periprocedural complication.
4. Discussion
4.1. Review of contemporary extraction methods
Historically, there were no specialized tools for lead extraction.
Pulling force in the form of simple traction or occasionally
through weights and a pulley system was given to slowly break
the lead free of its attachments. However, these techniques
often failed, which resulted in broken leads with fragments left
behind or damage to vital body structures and serious
complications. As a modiﬁcation, tools like standard stylets
(nonlocking), snares, sutures, grasping or other devices, and
ﬁxation screws have been used to make lead extraction safer
and more successful. Sheaths made of metal, Teﬂon, polypro-
pylene, or other materials that require manual advancementFig. 4 – Trapped fragment of permacatheter into right
ventricle and superior vena cava.over the lead are also used relying on force to free the lead and
are much more effective than simple traction. Laser Sheaths,
which employ ﬁberoptics to transmit laser light, and Electro-
surgical Sheaths that use radiofrequency energy to disrupt the
ﬁbrotic attachments are other modiﬁcations with reasonable
success rate.8–13 Rotating Threaded Tip Sheath and Telescop-
ing Sheaths are also described. (These sheaths use mechanical
(standard polypropylene or newer rotational EvolutionTM
sheaths), electrical (Electrosurgical Dissection Sheath, Perfec-
ta®), or laser photoablative energy (Spectranetics, Inc.) to pass
through the binding site. The goal is to safely advance the
sheath through the binding sites and vasculature to the
electrode–myocardial interface.)
The sheaths can be introduced either through the implant
site (least chances of infection, single-site access), or whereFig. 6 – Retrieved fragment of permacatheter.
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pected, and internal jugular and femoral routes can be used
(more straight in approach: leads freed from access site,
‘‘snared’’ to IJV/femoral vein).
Extraction from the femoral route may be required if the
lead has been completely severed, although some operators
prefer the femoral approach as their primary method of
extraction. Using one of a variety of snares and guidewires, the
lead may be grasped and pulled down into the atrium or
inferior vena cava. At this point, the free end of the lead can be
grasped in a snare and pulled into the femoral sheath. The
sheath is advanced to provide countertraction as necessary
and the lead is removed. This approach is often best for
attempting to grasp fragments of a lead that has fallen apart
during an extraction attempt from above.
4.2. Complications of contemporary extraction methods
Complications from lead extraction are primarily related to the
possibility of damage to the venous system and myocardium.
The death rate should be in the range of 0.3%, with other major
complications <1.5%.14 Major complications include death,
cardiac avulsion or tear, vascular tear, and pulmonary
embolism. Death is almost always due to rapid and massive
blood loss. Pericardial tamponade and tears in the venous
system that are above the pericardial reﬂection resulting in
massive hemothorax are other known signiﬁcant complica-
tions. It is for these reasons that preparation for such
complications must be made.
Minor complications like venous thrombosis, pocket
hematoma, vascular damage at the extraction site requiring
repair, air embolism, migration of lead fragment, and minor
hemothorax or pneumothorax require prompt treatment, but
are usually not life threatening in most instances.
4.3. Recent developments
With the development of the discipline and guidelines,15 we
have witnessed a growth in the community of transvenous
lead extraction (TLE) experts coincident with a marked decline
in the incidence of procedure-related morbidity and mortality,
with more recent registries at high-volume centers reporting
high success rates with exceedingly low complication rates.
Coming back to our cases, there was no periprocedural
complication in any of them. Regarding the second case,
pigtail could have been used but there is risk of entanglement
with it while EP ablation catheter can be hooked and looped
easily around the lead. Use of laser sheaths16 has been
documented but that option is not feasible and economical in
developing countries where resources are limited and also it is
possible only when at least one end is accessible from the
subclavian, jugulars, or cephalic vein. Other techniques15 used
for extraction like snare, baskets, and counter pressure are
possible only when free end is available for traction.
5. Conclusion
There are clear shortcomings between extraction guidelines
and actual practice. Newer lead extraction technology hasalways been a clinical requirement and technical expertise is
required to match these rising proportions of need for
extractions. Simple novel use of EP catheter to retrieve
intracardiac devices along with standard technique can be
an effective and safe method. This method can signiﬁcantly
reduce the number of major cardiovascular surgeries and
related complications.
Conﬂicts of interest
The authors have none to declare.
Acknowledgement
The authors thank Mr. Arnab De.
r e f e r e n c e s
1. Hammill SC, Kremers MS, Kadish AH, et al. Review of the ICD
Registry's third year, expansion to include lead data and
pediatric ICD procedures, and role for measuring
performance. Heart Rhythm. 2009;6:1397–1401.
2. Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker
and ICD generator malfunctions: analysis of Food and Drug
Administration annual reports. J Am Med Assoc.
2006;295:1901–1906.
3. DeFrances CJ, Lucas CA, Buie VC, et al. National hospital
discharge survey. Natl Health Stat Report. 2006;2008:1–20.
4. Eckstein J, Koller MT, Zabel M, et al. Necessity for surgical
revision of deﬁbrillator leads implanted long-term: causes
and management. Circulation. 2008;117:2727–2733.
5. Vatankulu MA, Goktekin O, Kaya MG, et al. Effect of long-
term resynchronization therapy on left ventricular
remodeling in pacemaker patients upgraded to biventricular
devices. Am J Cardiol. 2009;103:1280–1284.
6. Haqqani HM, Mond HG. The implantable cardioverter-
deﬁbrillator lead: principles, progress, and promises. Pacing
Clin Electrophysiol. 2009;32:1336–1353.
7. Maytin M, Epstein LM, Henrikson CA, et al. Lead extraction is
preferred for lead revisions and system upgrades: when less
is more. Circ Arrhythm Electrophysiol. 2010;3:413–424.
8. Anderson JM. Inﬂammatory response to implants. ASAIO J.
1988;11:101–107.
9. Al-Khadra AS, Wilkoff BL. Extraction of transvenous
pacemaker and deﬁbrillator leads. In: Singer I, ed. In:
Interventional electrophysiology 2nd ed. 2001; 819–841
[chapter 34, Implantable Cardioverter-Deﬁbrillators and
Pacemakers].
10. Smith MC, Love CJ. Extraction of transvenous pacing and
ICD leads. Pacing Clin Electrophysiol. 2008;31:736–752.
11. Wilkoff BL, Byrd CL, Love CJ, et al. Pacemaker lead extraction
with the laser sheath: results of the pacing lead extraction
with the excimer sheath (PLEXES) trial. J Am Coll Cardiol.
1999;33:1671–1676.
12. Epstein LM, Byrd CL, Wilkoff BL, et al. Initial experience with
larger laser sheaths for the removal of transvenous
pacemaker and implantable deﬁbrillator leads. Circulation.
1999;100:516–525.
13. Kennergren C, Bucknall CA, Butter C, et al. PLESSE
investigators group. Europace. 2007;9:651–656.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 9 2 – s 9 6S9614. Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the
contemporary setting: the LExICon study an observational
retrospective study of consecutive laser lead extractions. J
Am Coll Cardiol. 2010;55:579–586.
15. Deharo JC, Bongiorni MG, Rozkovec A, et al. Pathways for
training and accreditation for transvenous lead extraction: aEuropean Heart Rhythm Association position paper.
Europace. 2012;14:124–134.
16. Laurence M, Epstein. Charles L, et al. Initial experience with
larger laser sheaths for the removal of transvenous
pacemaker and implantable deﬁbrillator leads. Circulation.
1999;100:516–525.
